Holding(s) in Company

Summary by AI BETAClose X

UBS Group AG, through UBS AG, has acquired a significant stake in Renalytix PLC, now holding 5.958468% of the voting rights, which equates to 39,949,108 shares. This notification follows an acquisition of voting rights that crossed a threshold on September 30, 2026, and was reported to the issuer on October 1, 2026. Previously, UBS had no reported holdings in Renalytix PLC.

Disclaimer*

UK 100

Latest directors dealings